17089-350 NDC - GUNA-AWARENESS (BETAINE - BUFO BUFO CUTANEOUS GLAND - CALCIUM CARBONATE - CHROMIC SULFATE - CICUTA VIROSA ROOT - COPPER - FOLIC ACID - GOLD - COBALAMIN - IRON - LACHESIS MUTA VENOM - MELATONIN - MOLYBDENUM - NEUROTROPHIN-3 - NEUROTROPHIN-4 - OXYTOCIN - SILICON DIOXIDE - SUS SCROFA FRONTAL LOBE - SUS SCROFA TEMPORAL LOBE - THYROTROPIN ALFA - UBIDECARENONE - VANADIUM - ZINC - BRAIN-DERIVED NEUROTROPHIC FACTOR HUMAN -)

Drug Information

  • Product NDC: 17089-350
  • Proprietary Name: GUNA-AWARENESS
  • Non Proprietary Name: BETAINE - BUFO BUFO CUTANEOUS GLAND - CALCIUM CARBONATE - CHROMIC SULFATE - CICUTA VIROSA ROOT - COPPER - FOLIC ACID - GOLD - COBALAMIN - IRON - LACHESIS MUTA VENOM - MELATONIN - MOLYBDENUM - NEUROTROPHIN-3 - NEUROTROPHIN-4 - OXYTOCIN - SILICON DIOXIDE - SUS SCROFA FRONTAL LOBE - SUS SCROFA TEMPORAL LOBE - THYROTROPIN ALFA - UBIDECARENONE - VANADIUM - ZINC - BRAIN-DERIVED NEUROTROPHIC FACTOR HUMAN -
  • Active Ingredient(s): 3 [hp_X]/30mL BETAINE; 4 [hp_C]/30mL BRAIN-DERIVED NEUROTROPHIC FACTOR HUMAN; 12 [hp_X]/30mL BUFO BUFO CUTANEOUS GLAND; 3 [hp_X]/30mL CALCIUM CARBONATE; 3 [hp_X]/30mL CHROMIC SULFATE; 12 [hp_X]/30mL CICUTA VIROSA ROOT; 3 [hp_X]/30mL COBALAMIN; 12 [hp_X]/30mL COPPER; 3 [hp_X]/30mL FOLIC ACID; 12 [hp_X]/30mL GOLD; 3 [hp_X]/30mL IRON; 12 [hp_X]/30mL LACHESIS MUTA VENOM; 4 [hp_C]/30mL MELATONIN; 3 [hp_X]/30mL MOLYBDENUM; 4 [hp_C]/30mL NEUROTROPHIN-3; 4 [hp_C]/30mL NEUROTROPHIN-4; 6 [hp_X]/30mL OXYTOCIN; 12 [hp_X]/30mL SILICON DIOXIDE; 6 [hp_X]/30mL SUS SCROFA FRONTAL LOBE; 6 [hp_X]/30mL SUS SCROFA TEMPORAL LOBE; 3 [hp_X]/30mL THYROTROPIN ALFA; 3 [hp_X]/30mL UBIDECARENONE; 6 [hp_X]/30mL VANADIUM; 3 [hp_X]/30mL ZINC
  • Administration Route(s): ORAL
  • Dosage Form(s): SOLUTION/ DROPS
  • Pharmacy Class(es): Allergens [CS]; Blood Coagulation Factor [EPC]; Calcium [CS]; Cations; Divalent [CS]; Cell-mediated Immunity [PE]; Copper [CS]; Copper-containing Intrauterine Device [EPC]; Decreased Embryonic Implantation [PE]; Decreased Sperm Motility [PE]; Increased Coagulation Factor Activity [PE]; Increased Histamine Release [PE]; Increased Uterine Smooth Muscle Contraction or Tone [PE]; Inhibit Ovum Fertilization [PE]; Methylating Activity [MoA]; Methylating Agent [EPC]; Oxytocic [EPC]; Oxytocin [CS]; Standardized Chemical Allergen [EPC]; Thyroid Stimulating Hormone [EPC]; Thyrotropin [CS]

Labeler Information

Field Name Field Value
Labeler Name: Guna spa
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:4/16/2008

Package Information

No. Package Code Package Description Billing Unit
117089-350-181 BOTTLE, DROPPER in 1 BOX (17089-350-18) / 30 mL in 1 BOTTLE, DROPPER

NDC Record

Field Name Field Value Definition
PRODUCT NDC17089-350The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEGUNA-AWARENESSThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEBETAINE - BUFO BUFO CUTANEOUS GLAND - CALCIUM CARBONATE - CHROMIC SULFATE - CICUTA VIROSA ROOT - COPPER - FOLIC ACID - GOLD - COBALAMIN - IRON - LACHESIS MUTA VENOM - MELATONIN - MOLYBDENUM - NEUROTROPHIN-3 - NEUROTROPHIN-4 - OXYTOCIN - SILICON DIOXIDE - SUS SCROFA FRONTAL LOBE - SUS SCROFA TEMPORAL LOBE - THYROTROPIN ALFA - UBIDECARENONE - VANADIUM - ZINC - BRAIN-DERIVED NEUROTROPHIC FACTOR HUMAN -The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMESOLUTION/ DROPSThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE4/16/2008This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEGuna spaName of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEBETAINE; BRAIN-DERIVED NEUROTROPHIC FACTOR HUMAN; BUFO BUFO CUTANEOUS GLAND; CALCIUM CARBONATE; CHROMIC SULFATE; CICUTA VIROSA ROOT; COBALAMIN; COPPER; FOLIC ACID; GOLD; IRON; LACHESIS MUTA VENOM; MELATONIN; MOLYBDENUM; NEUROTROPHIN-3; NEUROTROPHIN-4; OXYTOCIN; SILICON DIOXIDE; SUS SCROFA FRONTAL LOBE; SUS SCROFA TEMPORAL LOBE; THYROTROPIN ALFA; UBIDECARENONE; VANADIUM; ZINCAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH3; 4; 12; 3; 3; 12; 3; 12; 3; 12; 3; 12; 4; 3; 4; 4; 6; 12; 6; 6; 3; 3; 6; 3 
ACTIVE INGRED UNIT[hp_X]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL 
PHARM CLASSESAllergens [CS], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased Uterine Smooth Muscle Contraction or Tone [PE], Inhibit Ovum Fertilization [PE], Methylating Activity [MoA], Methylating Agent [EPC], Oxytocic [EPC], Oxytocin [CS], Standardized Chemical Allergen [EPC], Thyroid Stimulating Hormone [EPC], Thyrotropin [CS] 

Download Record

Download this NDC record record in Text format: Export

Download this NDC record record in Excel (CSV) format: Export

Download this NDC record record in XML format: Export

This page was last updated on: 1/16/2026

Previous Code
Next Code